Related Experiment Video
Updated: Jul 30, 2025
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery
Joanna L Stollings1,2, Janelle O Poyant3, Christine M Groth4
1Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA.
Background:
Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs.
Research Question:
What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers?
Study Design And Methods:
This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC.
Results:
507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients.
Interpretation:
A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:22Myocarditis IV: Nursing Management
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:27Coronary Artery Disease V: Interprofessional Care
01:18Endocarditis III: Medical Management